More on TLX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $9.03 |
|
|||
| Open | $9.43 | ||||
| 52 Wk High | $2.18 | ||||
| 52 Wk Low | $0.30 | ||||
| Day High | $9.65 | ||||
| Day Low | $9.36 | ||||
| P/E | N/A | ||||
| EPS | $-3.32 | ||||
| Volume | 353,942 | ||||
- Wedbush Reiterates Outperform Rating on Telix Pharmaceuticals Ltd (TLX)
- Citi Adds Telix Pharmaceuticals Ltd (TLX) to 90-Day Upside Catalyst Watch List
- Telix Reports Third Quarter 2026 Financial Performance
- Telix and Ekalia to produce astatine-211 near Philadelphia
- Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.
- Profound Medical and Telix sign co-education deal on prostate care
- Telix Pharmaceuticals Ltd (TLX:AU) (TLX) PT Raised to AUD26 at UBS
- Telix begins U.S. commercial dosing of brain cancer imaging drug
- First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)
- H.C. Wainwright Reiterates Buy Rating on Telix Pharmaceuticals Ltd (TLX)
Entities mentioned with TLX
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- PDUFA | View Related Stories »
- Earnings | View Related Stories »
- Show More...
